Asia-Pacific Drug Development Solutions
Source: CMIC Group
In addition to Japan, CMIC Group has 135 active clinical trial sites in China, Thailand, Hong Kong, Vietnam, Malaysia, Singapore, Australia, New Zealand, Indonesia, Taiwan, South Korea and the Philippines. We have the capability to support our client’s clinical trials throughout Asia Pacific region.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more